WELCOME TO THE SURGICAL INTERVENTION TRIALS UNIT (SITU NDORMS)
SITU is one of seven Royal College of Surgeons of England specialist trials centres dedicated to evaluating surgical intervention, mainly by generating randomised control trial evidence. We are a multidisciplinary team who provide, guidance, training and support for the development of new surgical trials and future trialists. We draw upon the considerable methodological and practical trials expertise in Oxford including statistical, ethical, health economic, systematic review, clinical network resources and the IDEAL collaboration.
Currently, less than 5% of government funding for medical research goes into surgery
20 May 2022
To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.
Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain
6 April 2022
A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.
16 March 2022
NDORMS Professor of Musculoskeletal and Surgical Science, David Beard, has been named National Institute of Health Research (NIHR) Senior Investigator.
4 October 2021
Professor of Musculoskeletal and Surgical Science, David Beard, has been awarded an Honorary Fellowship by the British Orthopaedic Association.
Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshop.
Beard DJ. et al, (2021), Health technol assess, 25, 1 - 52
Cook JA. et al, (2021), Bmc pilot and feasibility studies
Considerations and Methods for Placebo Controls in Surgical Trials: State of the Art Review and ASPIRE Guidance
BEARD DJ. et al, (2019), The lancet